ℹ️
🇬🇧
Search
Search for people relevant for "Primary myelofibrosis"
Primary myelofibrosis
Person
Class
Person
Publication
Programmes
doc. MUDr. Anna Jonášová Ph.D.
Academic staff at First Faculty of Medicine
124 publications
Publications
publication
Guidelines of Czech working group for Ph- myeloproliferative disease (CZEMP) of Czech society of hematology for diagnosis and therapy of BCR/ABL negative myeloproliferation
2012 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
publication
Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases - principles and rationale of CZEMP recommendations
2011 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms
2024 |
First Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Science
publication
Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1
2023 |
Faculty of Science, Central Library of Charles University
publication
Luspatercept – a new contribution to the therapy of anaemia in patients with myelodysplastic syndrome
2023 |
First Faculty of Medicine
publication
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
2023 |
First Faculty of Medicine
publication
The benefit of luspatercept in the treatment of low‑risk myelodysplastic syndrome – case report
2023 |
First Faculty of Medicine
publication
Luspatercept představuje velký pokrok v terapii anemie u myelodysplastického syndromu
2023 |
First Faculty of Medicine
publication
RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS
2022 |
First Faculty of Medicine, Faculty of Science
publication
G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial
2022 |
First Faculty of Medicine, Faculty of Mathematics and Physics
Load more publications (114)
Loading network view...